-transparent.png){kind=logo}
The obstetric implications of the use of the beta-adrenoceptor antagonist atenolol have been evaluated in a prospective, randomized, double-blind, and placebo-controlled study involving 120 women with pregnancy-associated hypertension. The clinical interpretation of antenatal and intrapartum cardiotocographs was uninfluenced by atenolol. Human placental lactogen concentration fell in the atenolol group, but this was not an indicator of subsequent fetal distress. Other obstetric indices, such as urinary estriol excretion, were the same in both groups. Spontaneous premature labor occurred in five women receiving placebo but in none who received atenolol. Together with previously reported findings on pregnancy outcome, our study leads us to conclude that beta-blockers such as atenolol can appropriately be used in the management of hypertension during pregnancy.
P C Rubin, and
L Butters, and
D Clark, and
D Sumner, and
A Belfield, and
D Pledger, and
R A Low, and
J L Reid
February 1982,
Annals of internal medicine,
P C Rubin, and
L Butters, and
D Clark, and
D Sumner, and
A Belfield, and
D Pledger, and
R A Low, and
J L Reid
May 1993,
Clinical and experimental hypertension (New York, N.Y. : 1993),
P C Rubin, and
L Butters, and
D Clark, and
D Sumner, and
A Belfield, and
D Pledger, and
R A Low, and
J L Reid
July 1983,
Archives internationales de pharmacodynamie et de therapie,
P C Rubin, and
L Butters, and
D Clark, and
D Sumner, and
A Belfield, and
D Pledger, and
R A Low, and
J L Reid
January 1982,
British journal of clinical pharmacology,
P C Rubin, and
L Butters, and
D Clark, and
D Sumner, and
A Belfield, and
D Pledger, and
R A Low, and
J L Reid
November 1988,
International journal of dermatology,
P C Rubin, and
L Butters, and
D Clark, and
D Sumner, and
A Belfield, and
D Pledger, and
R A Low, and
J L Reid
November 1983,
European heart journal,
P C Rubin, and
L Butters, and
D Clark, and
D Sumner, and
A Belfield, and
D Pledger, and
R A Low, and
J L Reid
June 1991,
Prostaglandins, leukotrienes, and essential fatty acids,
P C Rubin, and
L Butters, and
D Clark, and
D Sumner, and
A Belfield, and
D Pledger, and
R A Low, and
J L Reid
June 1990,
Drugs,
P C Rubin, and
L Butters, and
D Clark, and
D Sumner, and
A Belfield, and
D Pledger, and
R A Low, and
J L Reid
April 1986,
The Journal of pharmacy and pharmacology,
P C Rubin, and
L Butters, and
D Clark, and
D Sumner, and
A Belfield, and
D Pledger, and
R A Low, and
J L Reid
December 1987,
British journal of clinical pharmacology,
